Memantine agonist action at dopamine D2High receptors

@article{Seeman2008MemantineAA,
  title={Memantine agonist action at dopamine D2High receptors},
  author={P. Seeman and C. Caruso and M. Lasaga},
  journal={Synapse},
  year={2008},
  volume={62}
}
Memantine is reported to improve symptoms in moderate cases of Alzheimer's disease and Parkinson's disease, but is also known to trigger psychosis in some Parkinson patients. Because these clinical features suggested a possible dopamine component of memantine action, we measured the potency of memantine on the functional high‐affinity state of dopamine D2 receptors, or D2High. Using [3H]domperidone to label D2 receptors, the memantine dissociation constant at D2High was 917 ± 23 nM for rat… Expand
Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
TLDR
There are numerous randomized, double-blind, placebo-controlled clinical trials showing that add-on treatment with memantine improves negative and cognitive symptoms, particularly the negative symptoms of schizophrenia, indicating that memantine as adjunctive therapy in schizophrenia helps to ameliorate negative symptoms and cognitive deficits. Expand
Influence of memantine on brain monoaminergic neurotransmission parameters in mice: neurochemical and behavioral study.
TLDR
The findings suggest that the increased locomotor activity and enhanced 5-HT-induced HTR by memantine may result from the reuptake and turnover inhibitions of 5- HT and dopamine. Expand
Management of moderate to severe Alzheimer's disease: focus on memantine.
Alzheimer's disease (AD) is the most common form of dementia, and one of the principal causes leading to death around the world. It is a progressive neurodegenerative disorder that still remainsExpand
Mechanism of block and behavioral effects of the N-methyl-D-aspartate receptor antagonists memantine and ketamine
Pharmacological inhibition of NMDA receptor activity by ketamine is accompanied by pyschotomimetic side-effects; however, the Alzheimer's disease therapeutic memantine blocks NMDA receptor activityExpand
Memantine alters striatal plasticity inducing a shift of synaptic responses toward long-term depression
TLDR
The results suggest that memantine could be used as treatment of neurological disorders in which DA D2 receptor represents a possible therapeutic target, and the actions exerted by memantine on striatal synaptic plasticity, and in particular the induction of LTD observed in SPNs, could be attributed to its ability to activateDA D2 receptors. Expand
Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats
TLDR
The findings show that, regardless of test delay, memantine and ketamine evoke similar behavioral effects at lower doses, consistent with NMDA receptors being both drugs' principal site of action, but can have divergent effects at higher doses. Expand
Memantine, an NMDA Receptor Antagonist, Prevents Thyroxin-induced Hypertension, but Not Cardiac Remodeling
TLDR
This is the first study to inspect the possible role of NMDA-R in the T4-stimulated cardiovascular disorders and concluded that NMda-R could play a key role in theT4-induced hypertension. Expand
INTERACTION OF MEMANTINE WITH ETHANOL CONSUMPTION AND DOPAMINERGIC FUNCTION IN HIGH ETHANOL PREFERRING RATS
ABSTRACT  Gloria E. Malpass. INTERACTION OF MEMANTINE WITH ETHANOL CONSUMPTION  AND DOPAMINERGIC FUNCTION IN HIGH ETHANOL PREFERRING RATS. (Under  the supervision of Dr. Brian A. McMillen) DepartmentExpand
Psychotomimetic-like behavioral effects of memantine in the mouse.
TLDR
The effects of memantine may be more limited to the ventral striatum including nucleus accumbens than those of METH, which is associated with dorsal striatal stimulation at high doses, which may have important implications for therapeutic uses of these drugs. Expand
Altered Actions of Memantine and NMDA-Induced Currents in a New Grid2-Deleted Mouse Line
TLDR
A new role for GRID2 is explored and the adverse effects of memantine in different genetic backgrounds are highlighted and the AMPA treatment enhanced memantine susceptibility in wild-type mice, which was indicated by balance sense and OKR impairments. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 31 REFERENCES
Distinct effects of amantadine and memantine on dopaminergic transmission in the rat striatum
TLDR
It is shown that amantadine and memantine differentially affect striatal dopaminergic transmission, which could indicate that these two related aminoadamantanes display distinct pharmacodynamic properties. Expand
Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics
TLDR
To determine the affinities of phencyclidine, ketamine, dizocilpine and LSD for the functional high-affinity state of the dopamine D2 receptor, D2High, their dissociation constants (Ki) were obtained on [3H]domperidone binding to human cloned dopamine D 2 receptors. Expand
Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex.
TLDR
It is demonstrated that the long known antiparkinson and antipastic substance, memantine (1-amino-3,5-dimethyladamantane), inhibits the binding of [ 3H]MK-801 to postmortem human brain homogenates at therapeutic concentrations. Expand
Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
TLDR
Preclinical data on memantine is summarized to provide evidence that it is indeed possible to develop clinically well tolerated NMDA receptor antagonists, a fact reflected in the recent interest of several pharmaceutical companies in developing compounds with similar properties to memantine. Expand
Therapeutic brain concentration of the NMDA receptor antagonist amantadine
TLDR
Results indicate that extracellular concentrations of amantadine (CSF and serum values in patients, striatal microdialysates in the rat) are in the range of its Ki-value at the PCP binding site, which is much higher than in brain tissue. Expand
Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study.
TLDR
The results suggest that memantine may improve parkinsonian symptoms independently of dopaminergic drugs and, in contrast to recent findings with amantadine, it has no effect on drug-induced dyskinesias. Expand
Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: A microdialysis study
TLDR
It is concluded that drugs influencing cognitive mechanisms induce changes in a number of neurotransmitters with the changes being both region and drug specific. Expand
Complete Conversion of Brain D2 Dopamine Receptors from the High‐ to the Low‐Affinity State for Dopamine Agonists, Using Sodium Ions and Guanine Nucleotide
TLDR
It is concluded that it is possible to convert brain D2 dopamine receptors completely into their low‐affinity state, in the presence of NaCl and a guanine nucleotide, providing that appropriate allowance is made for the serotonergic component of [3H]spiperone binding. Expand
Dopamine agonist action of phencyclidine
TLDR
A strong dopamine‐like agonist action at the functional high‐affinity state of the dopamine D2 receptor by the phencyclidine psychotomimetic is consistent with the dopamine hypothesis of psychosis. Expand
Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan)
The effects of D145 (1,3-dimethyl-5-aminoadamantan) and amantadine on dopaminergic mechanisms in the rat were investigated by use of pharmacological agents known to disrupt dopamine function, byExpand
...
1
2
3
4
...